Apixaban
Número de CAS
503612-47-3
Fórmula Molecular
C25H25N5O4
Peso Molecular
459.5
Pureza
98%
Punto de fusión
235-238°C
Solubilidad
DMSO (Slightly, Heated), Methanol (Slightly)
Apariencia
White to Off-White solid
Condiciones de almacenamiento
Refrigerator
Indicación
Venous thromboembolic
Descripción del Producto

Eliquis (apixaban), a direct inhibitor of factor Xa (FXa), was approved by the European Commission on May 18, 2011 for prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery.